Oxford COVID-19 vaccine developers encouraged by immune response

"We're very happy that we're seeing the right sort of immune response that will give protection, and not the wrong sort," Gilbert said.

Vial 1 of Box 1. This is the vaccine candidate to be used in Phase 1 clinical trial at the Clinical Biomanufacturing Facility (CBF) in Oxford, Britain, April 2, 2020. Picture taken April 2, 2020

(photo credit: SEAN ELIAS/HANDOUT VIA REUTERS)

ByREUTERS

JULY 1, 2020 19:07

Oxford COVID-19 vaccine developers encouraged by immune response

"We're very happy that we're seeing the right sort of immune response that will give protection, and not the wrong sort," Gilbert said.

This is how to reduce your workout to 30 effective minutes

Confronting Israel’s mental health emergency

Oxford COVID-19 vaccine developers encouraged by immune response

"We're very happy that we're seeing the right sort of immune response that will give protection, and not the wrong sort," Gilbert said.

See more on